Robeco Institutional Asset Management
USNA icon

Robeco Institutional Asset Management’s Usana Health Sciences USNA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-18,223
Closed -$491K 924
2025
Q1
$491K Buy
18,223
+3,887
+27% +$105K ﹤0.01% 835
2024
Q4
$515K Sell
14,336
-5,492
-28% -$197K ﹤0.01% 830
2024
Q3
$752K Sell
19,828
-3,929
-17% -$149K ﹤0.01% 804
2024
Q2
$1.07M Hold
23,757
﹤0.01% 763
2024
Q1
$1.15M Sell
23,757
-62
-0.3% -$3.01K ﹤0.01% 759
2023
Q4
$1.28M Hold
23,819
﹤0.01% 758
2023
Q3
$1.4M Buy
23,819
+5,064
+27% +$297K ﹤0.01% 742
2023
Q2
$1.18M Sell
18,755
-732
-4% -$46.1K ﹤0.01% 764
2023
Q1
$1.23M Hold
19,487
﹤0.01% 749
2022
Q4
$1.04M Sell
19,487
-3,182
-14% -$169K ﹤0.01% 774
2022
Q3
$1.27M Sell
22,669
-680
-3% -$38.1K ﹤0.01% 678
2022
Q2
$1.69M Sell
23,349
-2,180
-9% -$158K 0.01% 649
2022
Q1
$2.03M Buy
25,529
+2,474
+11% +$197K ﹤0.01% 639
2021
Q4
$2.33M Hold
23,055
0.01% 628
2021
Q3
$2.13M Sell
23,055
-18,246
-44% -$1.68M ﹤0.01% 653
2021
Q2
$4.23M Sell
41,301
-4,322
-9% -$443K 0.01% 601
2021
Q1
$4.45M Sell
45,623
-5,981
-12% -$584K 0.01% 574
2020
Q4
$3.98M Sell
51,604
-9,098
-15% -$701K 0.01% 582
2020
Q3
$4.47M Sell
60,702
-10,398
-15% -$766K 0.01% 530
2020
Q2
$5.22M Sell
71,100
-16,789
-19% -$1.23M 0.02% 527
2020
Q1
$5.08M Buy
87,889
+14,047
+19% +$811K 0.02% 539
2019
Q4
$5.8M Sell
73,842
-35,118
-32% -$2.76M 0.02% 580
2019
Q3
$7.45M Sell
108,960
-21,101
-16% -$1.44M 0.03% 525
2019
Q2
$10.3M Sell
130,061
-116,355
-47% -$9.24M 0.04% 459
2019
Q1
$20.7M Buy
246,416
+8,205
+3% +$688K 0.08% 337
2018
Q4
$27.9M Sell
238,211
-2,800
-1% -$328K 0.13% 220
2018
Q3
$29.1M Buy
241,011
+83,672
+53% +$10.1M 0.12% 234
2018
Q2
$18.1M Buy
157,339
+135,778
+630% +$15.7M 0.08% 292
2018
Q1
$1.85M Buy
21,561
+3,331
+18% +$286K 0.01% 674
2017
Q4
$1.35M Hold
18,230
0.01% 660
2017
Q3
$1.05M Hold
18,230
0.01% 650
2017
Q2
$1.17M Buy
18,230
+14,308
+365% +$917K 0.01% 645
2017
Q1
$226K Hold
3,922
﹤0.01% 788
2016
Q4
$240K Buy
3,922
+1,961
+100% +$120K ﹤0.01% 703
2016
Q3
$271K Buy
+1,961
New +$271K ﹤0.01% 748